International Journal of

Respiratory and Pulmonary MedicineISSN: 2378-3516


 Open Access DOI:10.23937/2378-3516/1410165

A Unique Presentation of Pulmonary Langerhans Cell Histiocytosis

Varun Srivatsav, MD and Kelsey Tallon, MD

Article Type: Case Report | First Published: December 10, 2021

Pulmonary langerhans cell histiocytosis (PLCH) is a diffuse lung disease that primarily affects young adults, with cigarette smoking playing a significant role in developing the disease. Patients with PLCH present with characteristic CT chest findings of small irregular nodules and upper zone cysts. Previously, larger nodules greater than 10 mm and cavitation have only been reported a few times in the literature. We describe the case of a 69-year-old male who presented with dyspnea, non-producti...

 Open Access DOI:10.23937/2378-3516/1410164

Pneumonia Due To Stenotrophomonas maltophila in the Immunocompetent Patient: A Case of Environmental Exposure

Ana Cardoso

Article Type: Letter to Editor | First Published: December 10, 2021

Stenotrophomonas maltophilia is a multi-resistant gram-negative bacterium, an opportunistic agent generally associated with nosocomial infections, particularly in immunocompromised patients, being usually found in the intensive care setting. However, its prevalence in patients without predisposing risk factors is very rare. We have identified and successfully treated a healthy, immunocompetent patient who developed a community acquired severe S. maltophilia pneumonia. We report the case of a 24-...

 Open Access DOI:10.23937/2378-3516/1410163

Prevalence and Outcomes of Systemic Sclerosis-Associated Interstitial Lung Disease at a Tertiary Level Hospital in KwaZulu Natal, South Africa: A Retrospective Review

Salah Tanish, Kennedy Nyamande and K de Vasconcellos

Article Type: Research Article | First Published: December 10, 2021

Interstitial lung disease (ILD) is one of the most serious complications among patients with scleroderma. It is associated with significant morbidity and mortality. Little is known about the epidemiology of scleroderma associated ILD in sub-Saharan Africa. Thus, we aimed to determine the prevalence, clinical characteristics and outcomes of patients with scleroderma -ILD. A retrospective electronic chart review was conducted of patients with systemic sclerosis seen between January 2010 and Decem...

Volume 8
Issue 4